# Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia

> **NCT01768403** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1236 (actual)

## Conditions studied

- Hypercholesterolemia
- Cardiovascular Disease
- Hypertension
- Diabetes
- Coronary Heart Disease
- Peripheral Arterial Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01768403
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 1236 (ACTUAL)
- **Last updated:** 2013-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01768403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01768403, "Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01768403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*